Open Access

©NIJSES ONLINE ISSN: 2992-5819

PRINT ISSN: 2992-6149
Publications

NEWPORT INTERNATIONAL JOURNAL OF SCIENTIFIC

AND EXPERIMENTAL SCIENCES (NIJSES)

Volume 4 Issue 2 2023

Page | 10
https://doi.org/10.59298/NIJSES/2023/10.2.1111

Neutrophil-Derived Inflammation and Pregnancy

Outcomes

*
Emmanuel Ifeanyi Obeagu1, Getrude Uzoma Obeagu2, Matthew
Chibunna Igwe3, Esther Ugo Alum4,5 and Okechukwu Paul-Chima Ugwu5
1
Department of Medical Laboratory Science, Kampala International
University, Uganda.
2
School of Nursing Science, Kampala International University, Uganda.
3
Department of Public Health, Kampala International University,
Uganda.
4
Department of Biochemistry, Ebonyi State University, Abakaliki, Ebonyi
State, Nigeria.
5
Department of Publication and Extensions, Kampala International
University, Uganda.
*
Corresponding author: Emmanuel Ifeanyi Obeagu, Department of
Medical Laboratory Science, Kampala International University, Uganda,
emmanuelobeagu@yahoo.com, ORCID: 0000-0002-4538-0161

ABSTRACT
Inflammation, orchestrated by immune cells like neutrophils, plays a crucial role in maintaining homeostasis and
protecting against pathogens. However, during pregnancy, the delicate balance of immune responses is paramount
to support fetal development while safeguarding maternal health. Neutrophils, as pivotal contributors to the innate
immune system, significantly influence the inflammatory milieu, yet excessive or dysregulated neutrophil-derived
inflammation can impact pregnancy outcomes. This paper aims to dissect the multifaceted role of neutrophil-derived
inflammation in shaping pregnancy outcomes. It delves into the mechanisms by which neutrophils orchestrate
inflammatory responses during gestation and scrutinizes the implications of heightened inflammation on maternal-
fetal health. Specifically, it explores the association between increased neutrophil-driven inflammation and adverse
outcomes such as preterm birth, preeclampsia, intrauterine growth restriction, and fetal developmental
abnormalities. Examining the intricate balance between protective and detrimental roles of neutrophil-derived
inflammation, this review assesses alterations in neutrophil functions, activation pathways, and the release of
inflammatory mediators during normal and pathological pregnancies. Additionally, it evaluates potential regulatory
mechanisms governing neutrophil-derived inflammation and identifies putative biomarkers indicative of heightened
inflammatory responses linked to adverse pregnancy outcomes. The clinical implications of understanding the
impact of neutrophil-derived inflammation on pregnancy outcomes are highlighted, emphasizing its significance in
obstetric care, prenatal monitoring, and potential therapeutic interventions. Furthermore, this review delineates the

Obeagu et al., 2023

This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited
 Open Access
©NIJSES ONLINE ISSN: 2992-5819
PRINT ISSN: 2992-6149
Publications
critical need for future research avenues focusing on molecular investigations, therapeutic modulation of neutrophil-
driven inflammation, and longitudinal studies to elucidate the long-term consequences on maternal and fetal well-
being. In conclusion, unraveling the intricate interplay between neutrophil-derived inflammation and pregnancy
outcomes is imperative. A deeper understanding of these interactions holds promise for informing clinical strategies,
improving prenatal care, and ultimately optimizing maternal and fetal health.
Keywords: Neutrophil, Inflammation and Pregnancy Outcomes.
Page | 11
INTRODUCTION
Pregnancy orchestrates a complex interplay of immunological adaptations to support fetal growth and protect
against potential threats while maintaining maternal well-being. In this intricate balance, immune cells, particularly
neutrophils, emerge as central players in modulating the inflammatory milieu throughout gestation [1-3].
Neutrophils, traditionally recognized for their role in combating infections through rapid responses and
inflammatory mechanisms, are increasingly scrutinized for their impact on pregnancy outcomes [4-6]. The immune
landscape during pregnancy undergoes dynamic alterations to accommodate the developing fetus, navigating the
challenge of defending against pathogens while tolerating the semi-allogeneic nature of the placenta [7-9]. Amidst
this immune adaptation, neutrophils stand poised at the forefront of the innate immune defense, playing a dual role
in immune surveillance and inflammation [10]. This paper aims to dissect the multifaceted role of neutrophil-
derived inflammation in the context of pregnancy outcomes. It navigates the landscape of innate immunity during
gestation, emphasizing the intricate interplay between neutrophils and inflammatory responses in both physiological
and pathological pregnancies. Understanding the mechanisms by which neutrophil-driven inflammation contributes
to adverse pregnancy outcomes, including preterm birth, preeclampsia, intrauterine growth restriction, and fetal
developmental abnormalities, is paramount. In this pursuit, we delve into the complex interrelationships between
neutrophils and the inflammatory microenvironment of the uteroplacental unit, evaluating the potential implications
of dysregulated neutrophil-derived inflammation on maternal-fetal health. Additionally, we explore the regulatory
mechanisms governing neutrophil activation, the release of inflammatory mediators, and the potential utility of
biomarkers associated with heightened inflammation as predictive tools for adverse pregnancy outcomes. The
significance of comprehending the impact of neutrophil-derived inflammation on pregnancy outcomes extends to
clinical practice, necessitating a deeper understanding to inform obstetric care, prenatal monitoring, and therapeutic
interventions [11-13]. Ultimately, uncovering the nuanced role of neutrophil-driven inflammation during gestation
holds promise for deciphering pathways to optimize maternal-fetal health and offers avenues for future research to
bridge knowledge gaps in this critical realm of perinatal immunology.
Neutrophil Functions and Inflammatory Responses
Neutrophils, as essential components of the innate immune system, play a pivotal role in mounting inflammatory
responses to combat infections and maintain tissue homeostasis [14-16]. Neutrophils are rapidly mobilized to sites
of infection or tissue injury through a process called chemotaxis [17]. They respond to chemical signals, such as
cytokines and chemokines released by damaged tissues or immune cells, migrating towards areas requiring
immediate immune defense. They use specialized receptors to recognize and internalize microbes into phagosomes,
where they deploy antimicrobial mechanisms to eliminate invaders [18], including the release of enzymes, reactive
oxygen species (ROS), and antimicrobial peptides. Neutrophils contribute to inflammation by releasing a range of
inflammatory mediators [19]. These include cytokines (such as TNF-alpha, IL-1, and IL-6), chemokines (like IL-
8), and lipid mediators (prostaglandins, leukotrienes), amplifying the local immune response and recruiting other
immune cells to the site of infection. Neutrophils have the capability to release extracellular traps known as
neutrophil extracellular traps (NETs). These are web-like structures composed of DNA, histones, and antimicrobial
proteins, aimed at trapping and neutralizing pathogens, preventing their spread [20]. Neutrophils generate Reactive
Oxygen Species (ROS), such as superoxide radicals and hydrogen peroxide, as part of their antimicrobial arsenal.
These ROS have potent antimicrobial properties, aiding in the destruction of engulfed pathogens [21]. They
undergo apoptosis, facilitating their removal by macrophages and subsequent resolution of the inflammatory
response to prevent tissue damage and promote healing [22]. Neutrophils interact with various immune cells,
including macrophages, dendritic cells, and lymphocytes, influencing the adaptive immune response. They can
modulate the activation and function of other immune cells through the release of cytokines and direct cell-cell
interactions [23]. Neutrophils are versatile immune cells that respond swiftly to infections by deploying a range of
mechanisms to combat pathogens and regulate the inflammatory milieu [24-27]. Understanding their multifaceted
functions in inflammatory responses is crucial for comprehending their role in immune defense and their
contributions to both protective and pathological aspects of inflammation.

Obeagu et al., 2023

This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited
 Open Access
©NIJSES ONLINE ISSN: 2992-5819
PRINT ISSN: 2992-6149
Publications
Immunomodulation and Pregnancy Complications
Immunomodulation during pregnancy is a complex process that involves intricate interactions between maternal
immune responses and fetal development. Dysregulated or altered immune responses, including those mediated by
neutrophils, can contribute to various pregnancy complications [28-31]. Dysregulated immune responses,
characterized by heightened inflammation, can predispose pregnant individuals to preterm birth. Excessive
neutrophil-derived inflammation may contribute to premature labor by inducing cervical remodeling or initiating
uterine contractions, leading to preterm labor and delivery [32-36]. Preeclampsia, a multisystem disorder Page | 12
characterized by hypertension and proteinuria, is associated with altered immune responses. Dysfunctional
neutrophil activation and increased systemic inflammation have been implicated in the pathogenesis of preeclampsia,
contributing to endothelial dysfunction and maternal vascular complications [37-40]. Immunomodulation
imbalance can impact placental function, potentially leading to intrauterine growth restriction. Dysregulated
inflammatory responses involving neutrophils may impair placental blood flow and nutrient transport, affecting fetal
growth and development [41-44]. Altered immune responses during pregnancy can influence fetal development.
Excessive inflammation mediated by neutrophils might disrupt the delicate balance required for normal fetal
development, potentially contributing to congenital abnormalities or developmental disorders [45-49].
Immunomodulation plays a crucial role in protecting against infections during pregnancy. Dysregulated immune
responses, including impaired neutrophil functions, might increase susceptibility to infections, which can lead to
miscarriages or fetal loss [40, 50-53]. Immunomodulation is crucial for maintaining maternal-fetal tolerance,
preventing rejection of the semi-allogeneic fetus. Dysregulated immune responses, including aberrant neutrophil
activation, might disrupt this tolerance and contribute to pregnancy complications [41]. Heightened inflammatory
mediators released by activated neutrophils, such as cytokines and chemokines, can have detrimental effects on
placental function, vascular health, and fetal development, contributing to various pregnancy complications [40].
Understanding the role of immunomodulation, including the involvement of neutrophils, in pregnancy
complications is vital. It emphasizes the need for further research to elucidate the underlying mechanisms, identify
potential biomarkers, and develop targeted inter ventions aimed at modulating immune responses to mitigate the
risk of adverse pregnancy outcomes. This knowledge holds promise for improving maternal and fetal health
outcomes in complicated pregnancies.
Neutrophil Responses in Normal vs. Pathological Pregnancies
Neutrophils, as key players in immune responses, exhibit variations in their functions and responses in normal versus
pathological pregnancies [54-58]. During pregnancy, there's a gradual increase in neutrophil counts, particularly
in the second and third trimesters. This physiological rise in neutrophils is part of the overall changes in immune
cell distribution to support maternal and fetal health [59-62]. Neutrophils in normal pregnancies may exhibit
altered activation states. While there might be an increase in certain activation markers, they often maintain a
balanced functional profile, contributing to immune surveillance without inducing excessive inflammation [63-65].
They participate in immune regulation to prevent rejection of the semi-allogeneic fetus. In healthy pregnancies,
neutrophils contribute to a balanced inflammatory milieu. They engage in protective immune responses against
pathogens without inciting an exaggerated or detrimental inflammatory response [66-69] In pathological
pregnancies, such as those complicated by preeclampsia, intrauterine growth restriction, or infections, neutrophils
may exhibit dysregulated functions. This can include increased activation, altered chemotaxis, or exaggerated
release of inflammatory mediators [70-72]. Pathological pregnancies are often characterized by heightened systemic
inflammation. Dysregulated neutrophil responses can contribute to an imbalance in the inflammatory environment,
potentially leading to adverse pregnancy outcomes like preterm birth or complications related to placental
dysfunction. like preeclampsia or infections, aberrant neutrophil responses may exacerbate inflammation, endothelial
dysfunction, and vascular damage, contributing to the pathophysiology of these complications. Dysregulated
neutrophil responses in pathological pregnancies may impact placental function, fetal growth, and overall maternal-
fetal health. These altered immune responses might contribute to adverse outcomes such as preterm birth, fetal
developmental abnormalities, or maternal complications. Understanding the nuanced differences in neutrophil
responses between normal and pathological pregnancies is crucial for deciphering their role in contributing to or
mitigating the risks associated with adverse pregnancy outcomes. Further research is warranted to delineate the
mechanisms underlying these differences and identify potential therapeutic targets to manage pathological
conditions and optimize maternal and fetal health outcomes.
Regulation of Neutrophil Inflammation and Potential Biomarkers
Regulating neutrophil inflammation is essential for maintaining immune balance during pregnancy and preventing
adverse outcomes. Identifying potential biomarkers associated with neutrophil-driven inflammation can offer
insights into the monitoring and management of pregnancy complications [73-75]]. Regulatory factors, including
anti-inflammatory cytokines (e.g., IL-10, TGF-β) and specialized pro-resolving lipid mediators (e.g., lipoxins,
Obeagu et al., 2023
This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited
 Open Access
©NIJSES ONLINE ISSN: 2992-5819
PRINT ISSN: 2992-6149
Publications
resolvins), help mitigate excessive neutrophil-driven inflammation and promote the resolution of inflammation [76].
Programmed cell death or apoptosis is a crucial mechanism for terminating neutrophil-driven inflammation.
Accelerated apoptosis helps in the removal of neutrophils and limits their pro-inflammatory potential [77].
Intracellular signaling pathways and negative regulators modulate neutrophil activation, preventing exaggerated
responses that could lead to tissue damage. Control mechanisms like feedback loops regulate the extent and duration
of neutrophil activation [78].
Potential Biomarkers Associated with Neutrophil Inflammation Page | 13
Cytokines (e.g., IL-6, TNF-α) and chemokines (e.g., IL-8) released during neutrophil activation serve as potential
biomarkers of heightened inflammation. Elevated levels of these molecules in maternal circulation or at the placental
interface might indicate increased neutrophil-derived inflammation [79-80]. Metabolic alterations associated with
neutrophil activation, such as increased oxidative stress markers or changes in lipid metabolism, might serve as
indicative biomarkers of heightened inflammation. Analysis of biomarkers within the placental microenvironment
or amniotic fluid, where inflammatory processes occur, could provide insights into local neutrophil-driven
inflammation and its impact on pregnancy outcomes [81-84].
Clinical Implications
Monitoring neutrophil-derived inflammation and associated biomarkers could aid in early risk assessment for
pregnancy complications, allowing targeted interventions for high-risk individuals. Identification and validation of
specific biomarkers associated with heightened neutrophil-driven inflammation may facilitate diagnostic tests for
early detection and monitoring of pregnancy complications. Evaluation of neutrophil-related biomarkers might
serve as prognostic indicators for assessing the severity and predicting adverse outcomes in high-risk pregnancies.
Understanding the role of neutrophil-driven inflammation in pregnancy complications can help identify potential
therapeutic targets, enabling the development of targeted interventions to modulate inflammation.
Management Strategies
Targeted interventions aimed at modulating neutrophil-driven inflammation could be initiated early in pregnancies
identified as high risk. These interventions might include anti-inflammatory agents or immunomodulatory
treatments [85. Regular monitoring of neutrophil-related biomarkers in at-risk pregnancies can aid in surveillance,
allowing clinicians to track changes and adjust management strategies accordingly. Tailoring management
approaches based on individual patient profiles and the severity of neutrophil-driven inflammation could optimize
care for pregnant individuals at risk of complications [86-90]. Implementing lifestyle modifications or nutritional
interventions that have shown anti-inflammatory effects may help in managing neutrophil-driven inflammation. For
instance, promoting a balanced diet or supplementation with certain nutrients may modulate immune responses.
Developing pharmacological agents specifically targeting neutrophil activation, inflammatory mediators, or immune
regulatory pathways could offer novel therapeutic approaches [87-94]. Collaborative care involving obstetricians,
immunologists, and other specialists could ensure a comprehensive approach to managing pregnancy complications
associated with neutrophil-driven inflammation [90-94]. Providing education to pregnant individuals about the
implications of inflammatory responses on pregnancy outcomes and offering support and guidance for adherence to
management strategies. Recognizing the clinical implications of neutrophil-driven inflammation in pregnancy
complications enables the development of targeted management strategies aimed at early detection, intervention,
and personalized care. Further research to validate biomarkers and therapeutic approaches is essential to improve
clinical outcomes for pregnant individuals at risk of complications associated with altered neutrophil functions and
inflammation.
Future Directions and Research Implications
Understanding the role of neutrophil-driven inflammation in pregnancy complications opens avenues for further
research and potential interventions. Further investigations into the specific mechanisms underlying neutrophil-
driven inflammation in various pregnancy complications (e.g., preeclampsia, preterm birth) are essential.
Understanding how neutrophils contribute to the pathology of these conditions can identify potential therapeutic
targets [88]. Exploring interactions between neutrophils and other immune cells, such as macrophages, dendritic
cells, and T cells, in the context of pregnancy complications can unveil intricate immune responses and their impact
on maternal-fetal health. Continuation of research to identify and validate specific and reliable biomarkers associated
with neutrophil-driven inflammation in pregnancy complications. Validation of these biomarkers could enhance
early detection and prognosis. Investigating biomarkers within the placental microenvironment or amniotic fluid to
better understand local inflammatory processes and their correlation with systemic neutrophil-driven inflammation.
Development of targeted interventions or immunomodulatory therapies aimed at modulating neutrophil activation,
function, or inflammatory responses in high-risk pregnancies without compromising fetal development. Conducting
clinical trials to evaluate the efficacy and safety of novel therapeutic approaches targeting neutrophil-driven
inflammation in pregnant individuals with specific complications. Longitudinal studies to assess the long-term
Obeagu et al., 2023
This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited
 Open Access
©NIJSES ONLINE ISSN: 2992-5819
PRINT ISSN: 2992-6149
Publications
outcomes of pregnancies affected by neutrophil-driven inflammation. This includes evaluating the impact on
offspring health, immune development, and potential implications in adulthood. Large-scale population-based
studies to assess the prevalence and significance of altered neutrophil functions in diverse populations and their
association with varying pregnancy outcomes. Translating research findings into clinical practice by integrating
validated biomarkers or therapeutic interventions targeting neutrophil-driven inflammation into obstetric care
protocols. Advancing towards personalized medicine by tailoring management strategies based on individual patient
profiles and their specific neutrophil-related inflammatory status. Continued research efforts focusing on elucidating Page | 14
the mechanisms, identifying biomarkers, and developing targeted interventions related to neutrophil-driven
inflammation in pregnancy complications are imperative. These endeavors hold promise for advancing our
understanding and improving clinical outcomes in high-risk pregnancies affected by altered neutrophil functions
and associated inflammation.
CONCLUSION
The intricate interplay between neutrophil-driven inflammation and pregnancy outcomes presents a compelling area
of research with profound clinical implications. Neutrophils, pivotal components of the innate immune system, wield
significant influence over the inflammatory milieu during gestation, contributing to both protective and pathological
aspects of immune responses. Evidence increasingly suggests that dysregulated neutrophil functions and heightened
inflammation play critical roles in pregnancy complications such as preterm birth, preeclampsia, intrauterine growth
restriction, and fetal developmental abnormalities. Understanding the mechanisms by which altered neutrophil-
driven inflammation contributes to these adverse outcomes provides insights into potential diagnostic biomarkers
and therapeutic targets. Advancements in identifying specific biomarkers associated with neutrophil-driven
inflammation offer promise for early risk assessment, prognostication, and personalized management strategies in
pregnancies at risk of complications. Biomarker validation and integration into clinical practice could revolutionize
prenatal care, enabling timely interventions to mitigate risks and improve outcomes for both maternal and fetal
health. Further mechanistic studies unraveling the complexities of immune responses, immune cell interactions, and
the local placental microenvironment are warranted. These investigations are crucial for the development of targeted
immunomodulatory interventions aimed at regulating neutrophil-driven inflammation without compromising fetal
development. As research in this field progresses, translating these findings into clinical practice remains imperative.
Implementing validated biomarkers and personalized management approaches could revolutionize obstetric care,
ushering in an era of precision medicine tailored to the unique inflammatory profiles of pregnant individuals. In
conclusion, elucidating the intricate role of neutrophil-driven inflammation in pregnancy complications offers a
promising pathway towards improving risk assessment, early intervention, and personalized care. Continued
research endeavors aimed at understanding the mechanistic underpinnings and translating findings into clinical
practice hold the potential to transform maternal-fetal health outcomes in high-risk pregnancies.
REFERENCES
1. Obeagu EI, Agreen FC. Anaemia among pregnant women: A review of African pregnant teenagers. J Pub
Health Nutri. 2023; 6 (1). 2023;138. links/63da799664fc860638054562/Anaemia-among-pregnant-
women-A-review-of-African-pregnant-teenagers.pdf
2. Obeagu EI, Ezimah AC, Obeagu GU. Erythropoietin in the anaemias of pregnancy: a review. Int J Curr
Res Chem Pharm Sci. 2016;3(3):10-8. links/5710fae108ae846f4ef05afb/ERYTHROPOIETIN-IN-THE-
ANAEMIAS-OF-PREGNANCY-A-REVIEW.pdf.
3. Obeagu EI, Adepoju OJ, Okafor CJ, Obeagu GU, Ibekwe AM, Okpala PU, Agu CC. Assessment of
Haematological Changes in Pregnant Women of Ido, Ondo State, Nigeria. J Res Med Dent Sci.
2021;9(4):145-8. links/608a6728a6fdccaebdf52d94/Assessment-of-Haematological-Changes-in-Pregnant-
Women-of-Ido-Ondo.pdf.
4. Mincham KT, Bruno N, Singanayagam A, Snelgrove RJ. Our evolving view of neutrophils in defining the
pathology of chronic lung disease. Immunology. 2021 Dec;164(4):701-21.
5. Obeagu EI, Obeagu GU. Sickle Cell Anaemia in Pregnancy: A Review. International Research in Medical
and Health Sciences. 2023;6(2):10-3. http://irmhs.com/index.php/irmhs/article/view/111.
6. Jakheng SP, Obeagu EI. Seroprevalence of human immunodeficiency virus based on demographic and risk
factors among pregnant women attending clinics in Zaria Metropolis, Nigeria. J Pub Health Nutri. 2022; 5
(8). 2022;137. links/6317a6b1acd814437f0ad268/Seroprevalence-of-human-immunodeficiency-virus-
based-on-demographic-and-risk-factors-among-pregnant-women-attending-clinics-in-Zaria-Metropolis-
Nigeria.pdf.
7. Gray CC, Chen Y, Quiles-Ramirez Y, Ayala A. Acquired Immune Response to Infection. Cupiał, Michał,
Anna Szeląg-Sikora, Jakub Sikora, Joanna Rorat, and Marcin Niemiec." Information technology tools in
corporate knowledge management." Ekonomia i Prawo. Economics and Law.;17:5-15.
Obeagu et al., 2023
This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited
 Open Access
©NIJSES ONLINE ISSN: 2992-5819
PRINT ISSN: 2992-6149
Publications
8. Obeagu EI, Obeagu GU, Chukwueze CM, Ikpenwa JN, Ramos GF. Evaluation of Protein C, Protein S and
Fibrinogen of Pregnant Women with Malaria in Owerri Metropolis. Madonna University journal of
Medicine and Health Sciences. 2022;2(2):1-9.
9. Obeagu EI, Ikpenwa JN, Chukwueze CM, Obeagu GU. Evaluation of protein C, protein S and fibrinogen
of pregnant women in Owerri Metropolis. Madonna University Journal of Medicine and Health Sciences.
2022;2(1):292-8. https://madonnauniversity.edu.ng/journals/index.php/medicine/article/view/57.
10. Hammel JH, Zatorski JM, Cook SR, Pompano RR, Munson JM. Engineering in vitro immune-competent Page | 15
tissue models for testing and evaluation of therapeutics. Advanced Drug Delivery Reviews. 2022;
182:114111.
11. Sanford MD, Hollis RJ, Pfaller MA. Infections of the immunocompromised host. Antimicrob Agents
Chemother. 1999;43(1379ą1382):24.
12. Obeagu EI, Obeagu GU, Adepoju OJ. Evaluation of haematological parameters of pregnant women based
on age groups in Olorunsogo road area of Ido, Ondo state. J. Bio. Innov11 (3). 2022:936-41.
13. Obeagu EI. An update on utilization of antenatal care among pregnant Women in Nigeria. Int. J. Curr. Res.
Chem. Pharm. Sci. 2022;9(9): 21-6.DOI: 10.22192/ijcrcps.2022.09.09.003
14. Fox S, Leitch AE, Duffin R, Haslett C, Rossi AG. Neutrophil apoptosis: relevance to the innate immune
response and inflammatory disease. Journal of innate immunity. 2010;2(3):216-27.
15. Okoroiwu IL, Obeagu EI, Obeagu GU. Determination of clot retraction in preganant women attending
antenatal clinic in federal medical centre Owerri, Nigeria. Madonna University Journal of Medicine and
Health Sciences. 2022;2(2):91-7.
https://madonnauniversity.edu.ng/journals/index.php/medicine/article/view/67.
16. Obeagu EI, Hassan AO, Adepoju OJ, Obeagu GU, Okafor CJ. Evaluation of Changes in Haematological
Parameters of Pregnant Women Based on Gestational Age at Olorunsogo Road Area of Ido, Ondo State.
Nigeria. Journal of Research in Medical and Dental Science. 2021;9(12):462-
.links/61b1e32f0c4bfb675178bfa7/Evaluation-of-Changes-in-Haematological-Parameters-of-Pregnant-
Women-Based-on-Gestational-Age-at-Olorunsogo-Road-Area-of-Ido-Ondo-State-Nigeria.pdf.
17. Kienle K, Lämmermann T. Neutrophil swarming: an essential process of the neutrophil tissue response.
Immunological reviews. 2016;273(1):76-93.
18. Rosales C. Neutrophils at the crossroads of innate and adaptive immunity. Journal of Leucocyte Biology.
2020;108(1):377-96.
19. Wright HL, Moots RJ, Bucknall RC, Edwards SW. Neutrophil function in inflammation and inflammatory
diseases. Rheumatology. 2010;49(9):1618-31.
20. Zawrotniak M, Rapala-Kozik M. Neutrophil extracellular traps (NETs)-formation and implications. Acta
Biochimica Polonica. 2013;60(3).
21. Fialkow L, Wang Y, Downey GP. Reactive oxygen and nitrogen species as signaling molecules regulating
neutrophil function. Free Radical Biology and Medicine. 2007;42(2):153-64.
22. Potey PM, Rossi AG, Lucas CD, Dorward DA. Neutrophils in the initiation and resolution of acute
pulmonary inflammation: understanding biological function and therapeutic potential. The Journal of
pathology. 2019;247(5):672-85.
23. Leliefeld PH, Koenderman L, Pillay J. How neutrophils shape adaptive immune responses. Frontiers in
immunology. 2015; 6:471.
24. Othman A, Sekheri M, Filep JG. Roles of neutrophil granule proteins in orchestrating inflammation and
immunity. The FEBS journal. 2022;289(14):3932-53.
25. Anyiam AF, Obeagu EI, Obi E, Omosigho PO, Irondi EA, Arinze-Anyiam OC, Asiyah MK. ABO blood
groups and gestational diabetes among pregnant women attending University of Ilorin Teaching Hospital,
Kwara State, Nigeria. International Journal of Research and Reports in Hematology. 2022;5(2):113-21.
26. Obeagu EI. Gestational Thrombocytopaenia. J Gynecol Women’s Health. 2023;25(3):556163.
links/64b01aa88de7ed28ba95fccb/Gestational-Thrombocytopaenia.pdf.
27. Jakheng SP, Obeagu EI, Abdullahi IO, Jakheng EW, Chukwueze CM, Eze GC, Essien UC, Madekwe CC,
Madekwe CC, Vidya S, Kumar S. Distribution Rate of Chlamydial Infection According to Demographic
Factors among Pregnant Women Attending Clinics in Zaria Metropolis, Kaduna State, Nigeria. South
Asian Journal of Research in Microbiology. 2022;13(2):26-31.
28. Chen SJ, Liu YL, Sytwu HK. Immunologic regulation in pregnancy: from mechanism to therapeutic
strategy for immunomodulation. Clinical and Developmental Immunology. 2012.

Obeagu et al., 2023

This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited
 Open Access
©NIJSES ONLINE ISSN: 2992-5819
PRINT ISSN: 2992-6149
Publications
29. Obeagu EI, Ogbonna US, Nwachukwu AC, Ochiabuto O, Enweani IB, Ezeoru VC. Prevalence of Malaria
with Anaemia and HIV status in women of reproductive age in Onitsha, Nigeria. Journal of Pharmaceutical
Research International. 2021 Feb 23;33(4):10-9.
30. Obeagu EI, Abdirahman BF, Bunu UO, Obeagu GU. Obsterics characteristics that effect the newborn
outcomes. Int. J. Adv. Res. Biol. Sci. 2023;10(3): 134-43.DOI: 10.22192/ijarbs.2023.10.03.016
31. Obeagu EI, Ogunnaya FU. PREGNANCYINDUCED HAEMATOLOGICAL CHANGES: A KEY TO
MARTERNAL AND CHILD HEALTH. European Journal of Biomedical. 2023;10(8):42-3. Page | 16
links/64c890bddb38b20d6dad2c5c/PREGNANCY-INDUCED-HAEMATOLOGICAL-CHANGES-A-
KEY-TO-MARTERNAL-AND-CHILD-HEALTH.pdf.
32. Green ES, Arck PC. Pathogenesis of preterm birth: bidirectional inflammation in mother and fetus.
InSeminars in Immunopathology 2020 Aug (Vol. 42, No. 4, pp. 413-429). Berlin/Heidelberg: Springer
Berlin Heidelberg.
33. Ezeoru VC, Enweani IB, Ochiabuto O, Nwachukwu AC, Ogbonna US, Obeagu EI. Prevalence of Malaria
with Anaemia and HIV status in women of reproductive age in Onitsha, Nigeria. Journal of Pharmaceutical
Research International. 2021;33(4):10-9.
34. Okamgba OC, Nwosu DC, Nwobodo EI, Agu GC, Ozims SJ, Obeagu EI, Ibanga IE, Obioma-Elemba IE,
Ihekaire DE, Obasi CC, Amah HC. Iron Status of Pregnant and Post-Partum Women with Malaria
Parasitaemia in Aba Abia State, Nigeria. Annals of Clinical and Laboratory Research. 2017;5(4):206.
links/5ea97df145851592d6a8acf2/Iron-Status-of-Pregnant-and-Post-Partum-Women-with-Malaria-
Parasitaemia-in-Aba-Abia-State-Nigeria.pdf.
35. Eze RI, Obeagu EI, Edet FN. Frequency of Rh Antigen C And c among pregnant women in Sub-Urban
area in Eastern Nigeria. Madonna Uni J Med Health Sci. 2021;1(1):19-30.
36. Obeagu EI, Ofodile AC, Okwuanaso CB. A review of urinary tract infections in pregnant women: Risks
factors. J Pub Health Nutri. 2023; 6 (1). 2023; 137:26-35. links/63c3a9116fe15d6a571e8bba/A-review-of-
urinary-tract-infections-in-pregnant-women-Risks-factors.pdf.
37. Couceiro J, Matos I, Mendes JJ, Baptista PV, Fernandes AR, Quintas A. Inflammatory factors, genetic
variants, and predisposition for preterm birth. Clinical Genetics. 2021;100(4):357-67.
38. Obeagu EI, Obeagu GU, Musiimenta E. Post partum haemorrhage among pregnant women: Update on
risks factors. Int. J. Curr. Res. Med. Sci. 2023;9(2): 14-7.DOI: 10.22192/ijcrms.2023.09.02.003
39. Obeagu EI, Obeagu GU, Ogunnaya FU. Deep vein thrombosis in pregnancy: A review of prevalence and
risk factors. Int. J. Curr. Res. Chem. Pharm. Sci. 2023;10(8): 14-21.DOI: 10.22192/ijcrcps.2023.10.08.002
40. Jakheng SP, Obeagu EI, Jakheng EW, Uwakwe OS, Eze GC, Obeagu GU, Vidya S, Kumar S. Occurrence
of Chlamydial Infection Based on Clinical Symptoms and Clinical History among Pregnant Women
Attending Clinics in Zaria Metropolis, Kaduna State, Nigeria. International Journal of Research and
Reports in Gynaecology. 2022;5(3):98-105.
41. Bezemer RE, Schoots MH, Timmer A, Scherjon SA, Erwich JJ, van Goor H, Gordijn SJ, Prins JR. Altered
levels of decidual immune cell subsets in fetal growth restriction, stillbirth, and placental pathology.
Frontiers in immunology. 2020; 11:1898.
42. Okorie HM, Obeagu EI, Eze EN, Jeremiah ZA. Assessment of some haematological parameters in malaria
infected pregnant women in Imo state Nigeria. Int. J. Curr. Res. Biol. Med. 2018;3(9):1-4.DOI:
10.22192/ijcrbm.2018.03.09.001
43. Onyenweaku FC, Amah HC, Obeagu EI, Nwandikor UU, Onwuasoanya UF. Prevalence of asymptomatic
bacteriuria and its antibiotic susceptibility pattern in pregnant women attending private ante natal clinics
in Umuahia Metropolitan. Int J Curr Res Biol Med. 2017;2(2):13-23.DOI: 10.22192/ijcrbm.2017.02.02.003
44. Okoroiwu IL, Chinedu-Madu JU, Obeagu EI, Vincent CC, Ochiabuto OM, Ibekwe AM, Amaechi CO, Agu
CC, Anoh NV, Amadi NM. Evaluation of Iron Status, Haemoglobin and Protein Levels of Pregnant Women
in Owerri Metropolis. Journal of Pharmaceutical Research International. 2021;33(27A):36-43.
45. Obeagu EI, Njar VE, Obeagu GU. Infertility: Prevalence and Consequences. Int. J. Curr. Res. Chem. Pharm.
Sci. 2023;10(7):43-50.
46. Emeka-Obi OR, Ibeh NC, Obeagu EI, Okorie HM. Evaluation of levels of some inflammatory cytokines in
preeclamptic women in owerri. Journal of Pharmaceutical Research International. 2021;33(42A):53-65.
47. Obeagu EI, Faduma MH, Uzoma G. Ectopic Pregnancy: A Review. Int. J. Curr. Res. Chem. Pharm. Sci.
2023;10(4): 40-4.DOI: 10.22192/ijcrcps.2023.10.04.004
48. Obeagu EI, Gamade SM, Obeagu GU. The roles of Neutrophils in pregnancy. Int. J. Curr. Res. Med. Sci.
2023;9(5): 31-5.DOI: 10.22192/ijcrms.2023.09.05.005

Obeagu et al., 2023

This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited
 Open Access
©NIJSES ONLINE ISSN: 2992-5819
PRINT ISSN: 2992-6149
Publications
49. Eze R, Obeagu EI, Nwakulite A, Okoroiwu IL, Vincent CC, Okafor CJ, Chukwurah EF, Chijioke UO,
Amaechi CO. Evaluation of Copper Status and Some Red Cell Parameters of Pregnant Women in Enugu
State, South Eastern Nigeria. Journal of Pharmaceutical Research International. 2021;33(30A):67-71.
50. Obeagu EI, Obeagu GU. Molar Pregnancy: Update of prevalence and risk factors. Int. J. Curr. Res. Med.
Sci. 2023;9(7): 25-8.DOI: 10.22192/ijcrms.2023.09.07.005
51. Obeagu EI, Bunu UO. Factors that influence unmet need for family planning. International Journal of
Current Research in Biology and Medicine. 2023;8(1):23-7. Page | 17
52. Ibebuike JE, Ojie CA, Nwokike GI, Obeagu EI, Nwosu DC, Nwanjo HU, Agu GC, Ezenwuba CO, Nwagu
SA, Akujuobi AU. Barriers to utilization of maternal health services in southern senatorial district of Cross
Rivers state, Nigeria. International Journal of Advanced Multidisciplinary Research. 2017;4(8): 1-9.DOI:
10.22192/ijamr.2017.04.08.001
53. Emannuel G, Martin O, Peter OS, Obeagu EI, Daniel K. Factors Influencing Early Neonatal Adverse
Outcomes among Women with HIV with Post Dated Pregnancies Delivering at Kampala International
University Teaching Hospital, Uganda. Asian Journal of Pregnancy and Childbirth. 2023 ;6(1):203-11.
http://research.sdpublishers.net/id/eprint/2819/.
54. Morelli SS, Mandal M, Goldsmith LT, Kashani BN, Ponzio NM. The maternal immune system during
pregnancy and its influence on fetal development. Research and Reports in Biology. 2015:171-89.
55. Okorie HM, Obeagu EI, Eze EN, Jeremiah ZA. Assessment of coagulation parameters in malaria infected
pregnant women in Imo state, Nigeria. International Journal of Current Research in Medical Sciences.
2018;4(9):41-9.DOI: 10.22192/ijcrms.2018.04.09.006
56. Obeagu EI, Obeagu GU. Postpartum haemorrhage among women delivering through spontaneous vaginal
delivery: Prevalence and risk factors. Int. J. Curr. Res. Chem. Pharm. Sci. 2023;10(8):22-6.DOI:
10.22192/ijcrcps.2023.10.08.003
57. Obeagu E, Eze RI, Obeagu EI, Nnatuanya IN, Dara EC. ZINC LEVEL IN APPARENTLY PREGNANT
WOMEN IN URBAN AREA. Madonna University journal of Medicine and Health Sciences.
2022;2(1):134-48. https://www.journal.madonnauniversity.edu.ng/index.php/medicine/article/view/40.
58. Ogomaka IA, Obeagu EI. Malaria in Pregnancy Amidst Possession of Insecticide Treated Bed Nets (ITNs)
in Orlu LGA of Imo State, Nigeria. Journal of Pharmaceutical Research International. 2021;33(41B):380-6.
59. Edelstam G, Lowbeer C, Kral G, Gustafsson SA, Venge P. New reference values for routine blood samples
and human neutrophilic lipocalin during third-trimester pregnancy. Scandinavian journal of clinical and
laboratory investigation. 2001 Jan 1;61(8):583-91.
60. Obeagu EI, Ogunnaya FU, Obeagu GU, Ndidi AC. SICKLE CELL ANAEMIA: A GESTATIONAL
ENIGMA. migration. 2023; 17:18.
61. Ifeanyi OE, Uzoma OG. A review on erythropietin in pregnancy. J. Gynecol. Women’s Health. 2018;8(3):1-
4. https://www.academia.edu/download/56538560/A_Review_on_Erythropietin_in_Pregnancy.pdf.
62. Ifeanyi OE. A review on pregnancy and haematology. Int. J. Curr. Res. Biol. Med. 2018;3(5):26-8.DOI:
10.22192/ijcrbm.2018.03.05.006
63. Lee VM, Quinn PA, Jennings SC, Ng LL. Neutrophil activation and production of reactive oxygen species
in pre-eclampsia. Journal of hypertension. 2003;21(2):395-402.
64. Nwosu DC, Nwanjo HU, Obeagu EI, Ibebuike JE, Ezeama MC. Ihekireh. Changes in liver enzymes and
lipid profile of pregnant women with malaria in Owerri, Nigeria. International Journal of Current Research
and Academic Review. 2015;3(5):376-83.
65. Ibebuike JE, Ojie CA, Nwokike GI, Obeagu EI, Nwosu DC, Nwanjo HU, Agu GC, Ezenwuba CO, Nwagu
SA, Akujuobi AU. Factors that influence women’s utilization of primary health care services in Calabar
Cros river state, Nigeria. Int. J. Curr. Res. Chem. Pharm. Sci. 2017;4(7):28-33.
66. Bert S, Ward EJ, Nadkarni S. Neutrophils in pregnancy: New insights into innate and adaptive immune
regulation. Immunology. 2021;164(4):665-76.
67. Li X, Zhou J, Fang M, Yu B. Pregnancy immune tolerance at the maternal-fetal interface. International
Reviews of Immunology. 2020;39(6):247-63.
68. Eze R, Ezeah GA, Obeagu EI, Omeje C, Nwakulite A. Evaluation of iron status and some haematological
parameters of pregnant women in Enugu, South Eastern Nigeria. World Journal of Pharmaceutical and
Medical Research. 2021;7(5):251-4.
69. Elemchukwu Q, Obeagu EI, Ochei KC. Prevalence of Anaemia among Pregnant Women in Braithwaite
Memorial Specialist Hospital (BMSH) Port Harcourt. IOSR Journal of Pharmacy and Biological Sciences.
2014;9(5):59-64.

Obeagu et al., 2023

This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited
 Open Access
©NIJSES ONLINE ISSN: 2992-5819
PRINT ISSN: 2992-6149
Publications
70. Miller D, Motomura K, Galaz J, Gershater M, Lee ED, Romero R, Gomez-Lopez N. Cellular immune
responses in the pathophysiology of preeclampsia. Journal of Leukocyte Biology. 2022 Jan;111(1):237-60.
71. Akandinda M, Obeagu EI, Katonera MT. Non Governmental Organizations and Women’s Health
Empowerment in Uganda: A Review. Asian Research Journal of Gynaecology and Obstetrics. 2022;8(3):12-
6.
72. Vidya S. Sunil Kumar Shango Patience Emmanuel Jakheng, Emmanuel Ifeanyi Obeagu, Emmanuel William
Jakheng, Onyekachi Splendid Uwakwe, Gloria Chizoba Eze, and Getrude Uzoma Obeagu (2022). Page | 18
Occurrence of Chlamydial Infection Based on Clinical Symptoms and Clinical History among Pregnant
Women Attending Clinics in Zaria Metropolis, Kaduna State, Nigeria. International Journal of Research
and Reports in Gynaecology.;5(3):98-105.
73. Obeagu EI, Gamade SM, Obeagu GU. The roles of Neutrophils in pregnancy. Int. J. Curr. Res. Med. Sci.
2023;9(5):31-5.
74. Gamde MS, Obeagu EI. IRON DEFICIENCY ANAEMIA: ENEMICAL TO PREGNANCY. European
Journal of Biomedical. 2023;10(9):272-5. links/64f63358827074313ffaae7b/IRON-DEFICIENCY-
ANAEMIA-ENEMICAL-TO-PREGNANCY.pdf.
75. Emeka-Obi OR, Ibeh NC, Obeagu EI, Okorie HM. Evaluation of levels of some inflammatory cytokines in
preeclamptic women in owerri. Journal of Pharmaceutical Research International. 2021;33(42A):53-65.
76. Brennan E, Kantharidis P, Cooper ME, Godson C. Pro-resolving lipid mediators: Regulators of
inflammation, metabolism and kidney function. Nature Reviews Nephrology. 2021;17(11):725-39.
77. Filep JG, Ariel A. Neutrophil heterogeneity and fate in inflamed tissues: implications for the resolution of
inflammation. American Journal of Physiology-Cell Physiology. 2020;319(3):C510-32.
78. Azcutia V, Parkos CA, Brazil JC. Role of negative regulation of immune signaling pathways in neutrophil
function. Journal of leukocyte biology. 2018;103(6):1029-41.
79. Bordon J, Aliberti S, Fernandez-Botran R, Uriarte SM, Rane MJ, Duvvuri P, Peyrani P, Morlacchi LC,
Blasi F, Ramirez JA. Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis
in the protective versus deleterious inflammatory response in pneumonia. International Journal of
Infectious Diseases. 2013;17(2): e76-83.
80. Futosi K, Fodor S, Mócsai A. Neutrophil cell surface receptors and their intracellular signal transduction
pathways. International immunopharmacology. 2013;17(3):638-50.
81. Quintana M, Aranda S. Interactions of Carbon Nanostructures with Lipid Membranes: A Nano–Bio
Interface. InBiomaterial Mechanics 2017:117-146). CRC Press.
82. Emeka-Obi OR, Ibeh NC, Obeagu EI, Okorie HM. Studies of Some Haemostatic Variables in Preeclamptic
Women in Owerri, Imo State, Nigeria. Journal of Pharmaceutical Research International. 2021;33(42B):39-
48.
83. Obeagu EI, Obeagu GU. Postpartum haemorrhage among women delivering through spontaneous vaginal
delivery: Prevalence and risk factors. Int. J. Curr. Res. Chem. Pharm. Sci. 2023;10(8):22-6.
84. Obeagu EI, Obeagu GU. Sickle Cell Anaemia in Pregnancy: A Review. International Research in Medical
and Health Sciences. 2023;6(2):10-3.
85. Kapoor S, Opneja A, Nayak L. The role of neutrophils in thrombosis. Thrombosis research. 2018; 170:87-
96.
86. Gatto M, Zen M, Iaccarino L, Doria A. New therapeutic strategies in systemic lupus erythematosus
management. Nature Reviews Rheumatology. 2019;15(1):30-48.
87. Németh T, Sperandio M, Mócsai A. Neutrophils as emerging therapeutic targets. Nature reviews Drug
discovery. 2020 ;19(4):253-75.
88. Ward EJ, Bert S, Fanti S, Malone KM, Maughan RT, Gkantsinikoudi C, Prin F, Volpato LK, Piovezan AP,
Graham GJ, Dufton NP. Placental inflammation leads to abnormal embryonic heart development.
Circulation. 2023;147(12):956-72.
89. Ifeanyi OE, Chinedum OK, Chijioke UO. Trichomonas vaginalis: complications and treatment. Int J Curr
Res Med Sci. 2018;4(5):76-89.
90. Obeagu EI, Abdirahman BF, Bunu UO, Obeagu GU. Obsterics characteristics that effect the newborn
outcomes. Int. J. Adv. Res. Biol. Sci. 2023;10(3):134-43.
91. Chinedum OK, Ifeanyi OE, Uzoma UG, Ngozi GC. Prevalence of Trichomonas vaginalis among pregnant
women attending hospital in Irrua specialist teaching hospital in Edo State, Nigeria. J Dent Med Sci.
2014;13(9):79-82.

Obeagu et al., 2023

This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited
 Open Access
©NIJSES ONLINE ISSN: 2992-5819
PRINT ISSN: 2992-6149
Publications
92. Ezeani, N. N., Ibiam, U. A., Orji, O. U., Igwenyi, I. O., Aloke, C., Alum, E., ... & Ugwu, O. P. C. (2019). Effects
of aqueous and ethanol root extracts of Olax subscopioidea on inflammatory parameters in complete
Freund’s adjuvant-collagen type II induced arthritic albino rats. Pharmacognosy Journal, 11(1).
93. Alum, E. U., Ibiam, U. A., Ugwuja, E. I., Aja, P. M., Igwenyi, I. O., Offor, C. E., ... & Egwu, C. O. (2022).
Antioxidant Effect Of Buchholzia Coriacea Ethanol Leaf-Extract And Fractions On Freund’s Adjuvant-
Induced Arthritis In Albino Rats: A Comparative Study. Slovenian Veterinary Research, 59(1), 31-45.
94. Ibiam, U. A., Alum, E. U., Orji, O. U., Aja, P. M., Nwamaka, E. N., Ugwu, O. P. C., & Ekpono, E. U. (2018). Page | 19
Anti-Inflammatory Effects Of Buchholzia Coriacea Ethanol Leaf-Extract And Fractions In Freund's
Adjuvant-Induced Rheumatoid Arthritic Albino Rats. Indo American Journal Of Pharmaceutical Sciences, 5(7),
6341-6357.
CITE AS: Emmanuel Ifeanyi Obeagu, Getrude Uzoma Obeagu, Matthew Chibunna Igwe, Esther Ugo Alum
and Okechukwu Paul-Chima Ugwu (2023). Neutrophil-Derived Inflammation and Pregnancy Outcomes.
NEWPORT INTERNATIONAL JOURNAL OF SCIENTIFIC AND EXPERIMENTAL SCIENCES 4(2):10-
19. https://doi.org/10.59298/NIJSES/2023/10.2.1111

Obeagu et al., 2023

This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited